Changjiang Pharmaceutical Group Co., Ltd.

SZSE:300391 Voorraadrapport

Marktkapitalisatie: CN¥2.4b

Changjiang Pharmaceutical Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Changjiang Pharmaceutical Group has a total shareholder equity of CN¥737.2M and total debt of CN¥787.8M, which brings its debt-to-equity ratio to 106.9%. Its total assets and total liabilities are CN¥3.1B and CN¥2.4B respectively.

Belangrijke informatie

106.9%

Verhouding schuld/eigen vermogen

CN¥787.84m

Schuld

Rente dekkingsration/a
ContantCN¥6.74m
AandelenCN¥737.22m
Totaal verplichtingenCN¥2.35b
Totaal activaCN¥3.09b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%

Sep 30
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%

Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%

Aug 11
Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough

Jun 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Apr 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Feb 27
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Analyse van de financiële positie

Kortlopende schulden: 300391's short term assets (CN¥1.8B) do not cover its short term liabilities (CN¥1.8B).

Langlopende schulden: 300391's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥522.5M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 300391's net debt to equity ratio (106%) is considered high.

Schuld verminderen: 300391's debt to equity ratio has increased from 16.6% to 106.9% over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: 300391 has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 46.3% each year


Ontdek gezonde bedrijven